Small molecules could have big benefits in the battle against cancers
Posted: 15 January 2019 | Douglas J. Swirsky | No comments yet
Immunotherapy and targeted treatments, including targeted chemotherapy, continue to show great potential in cancer care. Future steps in their development will involve improving their ability to treat a wider range of cancers and a broader cross-section of the patient population, especially those for whom current treatments have shown limited efficacy…
Related topics
Drug Development, Oncology
Related conditions
Cancer
Related organisations
Rexahn Pharmaceuticals